Literature DB >> 194056

Epstein-barr virus-specific RNA. II. Analysis of polyadenylated viral RNA in restringent, abortive, and prooductive infections.

T Orellana, E Kieff.   

Abstract

The complexity and abundance of Epstein-Barr (EBV)-specific RNA in cell cultures restringently, abortively, and productively infected with EBV has been analyed by hybridization of the infected cell RNA with purified viral DNA. The data indicate the following. (i) Cultures containing productively infected cells contain viral RNA encoded by at least 45% of EBV DNA, and almost all of the species of viral RNA are present in the polyadenylated and polyribosomal RNA fractions. (ii) Restringently infected Namalwa and Raji cultures, which contain only intranuclear antigen, EBNA, and enhanced capacity for growth in vitro, contain EBV RNA encoded by at least 16 and 30% of the EBV DNA, respectively. The polyadenylated and polyribosomal RNA fractions of Raji and Namalwa cells are enriched for a class of EBV RNA encoded by approximately 5% of EBV DNA. The same EBV DNA sequences encode the polyadenylated and polyribosomal RNA of both Raji and Namalwa cells. (iii) After superinfection of Raji cultures with EBV (HR-1), the abortively infected cells contain RNA encoded by at least 41% of EBV DNA. The polyadenylated RNA of superinfected Raji cells is enriched for a class of EBV RNA encoded by approximately 20% of EBV HR-1 DNA. Summation hybridization experiments suggest that the polyadenylated RNA in superinfected Raji cells is encoded by the same DNA sequences as encode RNA present in Raji cells before superinfection, most of which is not polyadenylated. That the same EBV RNA sequences are present in the polyadenylated and polyribosomal fractions of two independently derived, restringently infected cell lines suggests that these RNAs may specify functions related to maintenance of the transformed state. The complexity of this class of RNA is adequate to specify a sequence of a least 5,000 amino acids. That only some RNA species are polyadenylated in restringent and abortive infection suggests that polyadenylation or whatever determines polyadenylation may play a role in the restricted expression of the EVB genome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194056      PMCID: PMC515722     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Units of transcription and translation: the relationship between heterogeneous nuclear RNA and messenger RNA.

Authors:  B Lewin
Journal:  Cell       Date:  1975-01       Impact factor: 41.582

2.  Molecular classes of heterogeneous nuclear RNA in sea urchin embryos.

Authors:  L M Dubroff; M Nemer
Journal:  J Mol Biol       Date:  1975-07-05       Impact factor: 5.469

3.  Possible role for poly(A) as an inhibitor of endonuclease activity in eukaryotic cells.

Authors:  C C Levy; M Schmukler; J J Frank; T P Karpetsky; P B Jewett; P A Hieter; S M LeGendre; R G Dorr
Journal:  Nature       Date:  1975-07-24       Impact factor: 49.962

4.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; B G ACHONG; Y M BARR
Journal:  Lancet       Date:  1964-03-28       Impact factor: 79.321

5.  Absence of polyadenylate segment in globin messenger RNA accelerates its degradation in Xenopus oocytes.

Authors:  G Marbaix; G Huez; A Burny; Y Cleuter; E Hubert; M Leclercq; H Chantrenne; H Soreq; U Nudel; U Z Littauer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

6.  Characterization of Epstein-Barr virus antigens. I. Biochemical analysis of the complement-fixing soluble antigen and relationship with Epstein-Barr virus-associated nuclear antigen.

Authors:  G Lenoir; M C Berthelon; M C Favre; G de-Thé
Journal:  J Virol       Date:  1976-02       Impact factor: 5.103

7.  Specificity of the S1 nuclease from Aspergillus oryzae.

Authors:  R C Wiegand; G N Godson; C M Radding
Journal:  J Biol Chem       Date:  1975-11-25       Impact factor: 5.157

8.  Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine.

Authors:  B Hampar; G Lenoir; M Nonoyama; J G Derger; S Chang
Journal:  Virology       Date:  1976-02       Impact factor: 3.616

9.  DNA of Epstein-Barr virus. I. Comparative studies of the DNA of Epstein-Barr virus from HR-1 and B95-8 cells: size, structure, and relatedness.

Authors:  R F Pritchett; S D Hayward; E D Kieff
Journal:  J Virol       Date:  1975-03       Impact factor: 5.103

10.  Evidence for post-transcriptional selection of viral mRNA in cells transformed by human adenovirus 12.

Authors:  M R Green; M Green; J K Mackey
Journal:  Nature       Date:  1976-05-27       Impact factor: 49.962

View more
  24 in total

1.  DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus.

Authors:  N Raab-Traub; R Pritchett; E Kieff
Journal:  J Virol       Date:  1978-08       Impact factor: 5.103

2.  Epstein-Barr virus-specific RNA. III. Mapping of DNA encoding viral RNA in restringent infection.

Authors:  A L Powell; W King; E Kieff
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  DNA of Epstein-Barr virus. II. Comparison of the molecular weights of restriction endonuclease fragments of the DNA of Epstein-Barr virus strains and identification of end fragments of the B95-8 strain.

Authors:  S D Hayward; E Kieff
Journal:  J Virol       Date:  1977-08       Impact factor: 5.103

4.  Transcription of the Epstein-Barr virus genome during latency in growth-transformed lymphocytes.

Authors:  J Sample; E Kieff
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Radiobiological inactivation of Epstein-Barr virus.

Authors:  E Henderson; L Heston; E Grogan; G Miller
Journal:  J Virol       Date:  1978-01       Impact factor: 5.103

6.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

7.  Definitive identification of a member of the Epstein-Barr virus nuclear protein 3 family.

Authors:  K Hennessy; F Wang; E W Bushman; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

8.  Epstein-Barr virus RNA. VI. Viral RNA in restringently and abortively infected Raji cells.

Authors:  W King; V Van Santen; E Kieff
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

9.  Epstein-Barr virus RNA VII: size and direction of transcription of virus-specified cytoplasmic RNAs in a transformed cell line.

Authors:  V van Santen; A Cheung; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

10.  Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.

Authors:  W King; A L Thomas-Powell; N Raab-Traub; M Hawke; E Kieff
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.